2005
Community Incidence of Hepatitis B and C among Reincarcerated Women
Macalino G, Vlahov D, Dickinson B, Schwartzapfel B, Rich J. Community Incidence of Hepatitis B and C among Reincarcerated Women. Clinical Infectious Diseases 2005, 41: 998-1002. PMID: 16142665, DOI: 10.1086/432936.Peer-Reviewed Original ResearchConceptsHepatitis B virusIncidence of HBVHCV infectionHepatitis BHepatitis C virus infectionC virus infectionDrug treatment servicesDrug-dependent personsIncident infectionsHIV testingBaseline prevalenceB virusCommunity incidenceIncidence rateVirus infectionTreatment servicesDrug useDrug dependenceInfectious diseasesInfectionSerum samplesIncidenceStudy periodWomenHCV
2003
Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988–2000: Description and Determinants
Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano D. Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988–2000: Description and Determinants. American Journal Of Epidemiology 2003, 158: 695-704. PMID: 14507606, DOI: 10.1093/aje/kwg209.Peer-Reviewed Original ResearchConceptsInjection drug usersDrug injection behaviorDrug usersIntravenous Experience (ALIVE) studyDrug treatment programsHistory of incarcerationLogistic regression modelsALIVE studySemiannual visitsMultinomial logistic regression modelsBaseline factorsChronic diseasesDrug injectionRecent overdoseCessation attemptsDrug use transitionsDrug injectorsCommunity outreach effortsLongitudinal patternsHigh mortalityEarly determinantsYounger ageTreatment programInjection behaviorStudy period
2002
Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.
Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Reports 2002, 117 Suppl 1: s135-45. PMID: 12435837, PMCID: PMC1913691.Peer-Reviewed Original ResearchConceptsDrug usersHealth consequencesSocioeconomic statusAdverse health consequencesPublic health interventionsIllicit drug useLow socioeconomic statusDrug use behaviorsDrug useHealth interventionsIndividual drug use behaviorRisk behaviorsSocial determinantsSocial factorsHealthStatusHigh levelsMedicationsFactors
1994
Voluntary Testing for Human Immunodeficiency Virus (HIV) in a Prison Population with a High Prevalence of HIV
Behrendt C, Kendig N, Dambita C, Horman J, Lowlor J, Vlahov D. Voluntary Testing for Human Immunodeficiency Virus (HIV) in a Prison Population with a High Prevalence of HIV. American Journal Of Epidemiology 1994, 139: 918-926. PMID: 8166142, DOI: 10.1093/oxfordjournals.aje.a117098.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV-seropositive inmatesVoluntary testingHIV seroprevalenceImmunodeficiency virusCurrent syphilis infectionHigh HIV seroprevalenceSimilar risk factorsMandatory HIV testingSyphilis infectionHIV infectionHIV serosurveyHIV testingRisk factorsHigh prevalencePrison entrantsLower riskPrison populationHigh-risk inmatesDrug useSimilar screeningRisk inmatesSeroprevalenceSerosurveyInfectionProfile of HIV seropositive inmates diagnosed in Maryland's state correctional system.
Kendig N, Stough T, Austin P, Kummer L, Swetz A, Vlahov D. Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system. Public Health Reports 1994, 109: 756-60. PMID: 7800784, PMCID: PMC1403577.Peer-Reviewed Original ResearchConceptsHIV infectionInfected inmatesHigher CD4 cell countsHuman immunodeficiency virus (HIV) infectionHIV-seropositive inmatesCD4 cell countImmunodeficiency virus infectionAnti-retroviral therapyVoluntary HIV testingPrimary care providersClinical case managementPublic health interventionsState correctional systemCorrectional settingsImmediate medical treatmentClinical profileHIV testingInitial diagnosisVirus infectionCare providersMedical treatmentCell countHealth interventionsCase managementInfection
1993
Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland
Vlahov D, Nelson K, Quinn T, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. European Journal Of Epidemiology 1993, 9: 566-569. PMID: 8307145, DOI: 10.1007/bf00209538.Peer-Reviewed Original Research
1990
Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons
Vlahov D, Muñoz A, Brewer F, Taylor E, Canner C, Polk B. Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons. AIDS 1990, 4: 345-350. PMID: 2350455, DOI: 10.1097/00002030-199004000-00010.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultBlack or African AmericanDistrict of ColumbiaForecastingHealth Planning OrganizationsHispanic or LatinoHIV AntibodiesHIV SeropositivityHIV SeroprevalenceHumansMaleMarylandMultivariate AnalysisPeriodicityPrisonersSeasonsState Health Planning and Development AgenciesSubstance Abuse, IntravenousUnited StatesConceptsIncoming male inmatesHIV-1HIV-1 seroprevalenceHIV-1 infectionEnzyme-linked immunosorbentMultivariate adjustmentPrevious serosurveysSignificant changesBlack raceMale inmatesPrison entrantsMultivariate analysisExcess serumMaryland prisonsWestern blotSeroprevalenceStudy periodAntibodiesDemographic variablesAgeSubgroupsAntibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons
Vlahov D, Lee H, Taylor E, Canavaggio M, Canner C, Burczak J, Saah A. Antibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1990, 3: 531-535. PMID: 1969961, DOI: 10.1097/00126334-199005000-00010.Peer-Reviewed Original ResearchConceptsHuman T-Lymphotropic Virus Type I/IIExact testIncoming male inmatesHIV-1 serostatusIntravenous drug usersPrevalence of HTLVFisher's exact testYears of ageSame calendar periodWestern blot techniqueType I/IIEpidemiological serosurveyScope of infectionMale inmatesCalendar periodRisk groupsHIV-1Drug usersHTLVMaryland prisonsChi 2Blot techniqueRoutine operational proceduresAntibodiesYear of entryCoinfection with tuberculosis and HIV-1 in male prison inmates.
Salive M, Vlahov D, Brewer T. Coinfection with tuberculosis and HIV-1 in male prison inmates. Public Health Reports 1990, 105: 307-10. PMID: 2113691, PMCID: PMC1580008.Peer-Reviewed Original ResearchConceptsHIV-1HIV-1 antibody testingHuman immunodeficiency virus type 1Latent HIV-1 infectionImmunodeficiency virus type 1HIV-1 infectionVirus type 1Case-control designAnergy testingTB infectionAntibody testingMantoux testingElevated riskSignificant associationPast exposureTuberculosisType 1InfectionState prison systemMale prison inmatesAssociationPrison inmatesMale inmatesIntake samplesAdmission
1989
Gonorrhea Prevalence in the Maryland State Prisons
ELLERBECK E, VLAHOV D, LIBONATI J, SALIVE M, BREWER T. Gonorrhea Prevalence in the Maryland State Prisons. Sexually Transmitted Diseases 1989, 16: 165-167. PMID: 2595513, DOI: 10.1097/00007435-198910000-00001.Peer-Reviewed Original ResearchTemporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987.
Vlahov D, Brewer F, Muñoz A, Hall D, Taylor E, Polk B. Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1989, 2: 283-90. PMID: 2786071.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) infectionHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Incoming male inmatesHIV-1 seroprevalenceIntravenous drug useType 1 infectionImmune deficiency syndromeCause of deathRisk of infectionVirus type 1Drug use variablesWestern blot techniqueCrude prevalenceRisk factorsUnivariate analysisDeficiency syndromeHIV-1Temporal trendsDrug usersDrug useExcess serumIncoming inmates